Current Opinion in Pulmonary Medicine · 6 Nov 2026
Melatonin in pediatric populations: promise or peril?
Judith A. Owens
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Purpose of review This review summarizes both the current evidence from clinical trials examining the use of exogenous melatonin for insomnia in children and adolescents and the recent literature raising potential concerns regarding melatonin as an over-the-counter (OTC) supplement. Given a number of caveats and the existence of remaining knowledge gaps, the overall aim of the review is to assist healthcare practitioners in decision-making for their pediatric patients and families. Recent findings While the evidence base supporting the efficacy and tolerability of melatonin for insomnia for children with neurodevelopmental disorders such as autism is generally considered robust, the literature in typically developing children is comparatively small. Studies over the past decade have raised concerns regarding the exponential increase in melatonin use in pediatric populations, reliability of the content of OTC melatonin products, the increase in accidental ingestions, especially in young children, and potential misuse of melatonin for unsupported indications. Summary While melatonin has a role in the management of pediatric insomnia as well as of circadian rhythm disorders, the existing literature supports behavioral interventions as the first-line treatment option. Potential pitfalls in the clinical use of melatonin in children are important to recognize and incorporate into best-practice recommendations.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (46)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 26 more references
A free account opens the rest of the citing papers and references on every paper’s page.